Alexander Armstrong

7PUBLICATIONS
57CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 27, 2026
Ruxolitinib for ciltacabtagene autoleucel-associated refractory diarrhea.

Viktoria Blumenberg, Filippo Birocchi, Angela Shih

|Nov 13, 2025
Ibrutinib and PD-1 Blockade Potentiate Mesothelin-Targeting CAR T-cell Therapy in Preclinical Models of Pancreatic Cancer.

Alexander Armstrong, Graziella van der Plancke, Sae Nishiguchi

|Sep 24, 2025
In vivo CRISPR screens identify modifiers of CAR T cell function in myeloma.

Nelson H Knudsen, Giulia Escobar, Felix Korell

|Sep 10, 2025
Tandem CAR-T cells targeting mesothelin and MUC16 overcome tumor heterogeneity by targeting one antigen at a time.

Diego Salas-Benito, Filippo Birocchi, Sangwoo Park

|Jun 04, 2025
IFN-γ-resistant CD28 CAR T cells demonstrate increased survival, efficacy, and durability in multiple murine tumor models.

Stefanie R Bailey, Hana N Takei, Giulia Escobar

|Jun 02, 2025
Secretion of a VEGF-Blocking scFv Enhances CAR T-cell Potency.

Valentina M Supper, Hannah Donner, Filippo Birocchi

Pageof 2